Biogen Inc. (BIIB): Price and Financial Metrics
Today's Latest Price: $274.48 USD
Sep 18 4:00pm Add BIIB to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
BIIB Stock Summary BIIB has a market capitalization of $43,453,881,520 -- more than approximately 95.61% of US stocks. With a price/earnings ratio of 7.33, Biogen Inc P/E ratio is greater than that of about only 10.66% of stocks in our set with positive earnings. In terms of volatility of its share price, BIIB is more volatile than only 1.92% of stocks we're observing. If you're looking for stocks that are quantitatively similar to Biogen Inc, a group of peers worth examining would be ADI, KLAC, ERIC, GLW, and ATVI. BIIB's SEC filings can be seen here. And to visit Biogen Inc's official web site, go to www.biogen.com.
BIIB Price/Volume Stats
Biogen Inc. (BIIB) Company Bio
Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. The company was founded in 1985 and is based in Cambridge, Massachusetts.
BIIB Latest News Stream
All News Types
Acquisition Barron's Biotechnology Buyback Commentary Corp. News Cramer Downgrade Earnings Guidance Down Guidance Up Insider Buying M&A Mgmt Change New Coverage (Bearish) New Coverage (Bullish) New Coverage (Neutral) Options Product News PT Lowered PT Raised PT Set (Bullish) PT Set (Neutral) Rating Reiterated (Bearish) Rating Reiterated (Bullish) Rating Reiterated (Neutral) Resumes Coverage (Bullish) Rumor Spin-off Trump Upgrade
Loading, please wait...
Latest BIIB News From Around the Web
Below are the latest news stories about Biogen Inc that investors may wish to consider to help them evaluate BIIB as an investment opportunity.
MISSISSAUGA, ON, Sept. 16, 2020 /CNW/ - Biogen Canada is proud to announce that it has been certified as a Great Place to Work® (GPTW) and named to the 2020 list of Best Workplaces™ in Healthcare.
If you want to know who really controls Biogen Inc. (NASDAQ:BIIB), then you'll have to look at the makeup of its share...
The biotech is facing several headwinds. Should investors get on board anyway?
These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q4 2020.
Concerned about the ongoing market turmoil? Here are three stocks to buy and hold through tough times.
Read More 'BIIB' Stories Here
BIIB Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.7672 seconds.